The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
daNIS-3: A phase II platform study of NIS793 and anti–PD-1 combined with standard of care (SoC) anti-cancer therapy for the second-line (2L) treatment (tx) of microsatellite-stable colorectal cancer (MSS CRC).
 
Filippo Pietrantonio
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daiichi-Sankyo; Incyte; Ipsen; Johnson&Johnson; Merck Serono; MSD Oncology; Pierre Fabre; Rottapharm Biotech; Seagen; SERVIER; Takeda
Consulting or Advisory Role - Agenus; Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; BMS; Daiichi-Sankyo; Gilead Sciences; GlaxoSmithKline; Incyte; Jazz Pharmaceuticals,; Johnson & Johnson/Janssen; Merck Serono; MSD Oncology; Pfizer; Pierre Fabre; Revolution Medicines; Rottapharm Biotech; SERVIER; Takeda
Research Funding - Agenus (Inst); Amgen (Inst); Astrazeneca (Inst); BeOne (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Johnson & Johnson/Janssen (Inst); Lilly (Inst); Rottapharm Biotech (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Johnson & Johnson/Janssen; Merck Serono; Pierre Fabre; Takeda Science Foundation
 
Iosune Baraibar
Honoraria - Amgen; AstraZeneca
Travel, Accommodations, Expenses - Amgen; Merck; SERVIER
 
Jiri Tomasek
Honoraria - Merck, Ipsen,MSD,BMS,Amgen, Roche, Zentiva, Pierre Fabre
Consulting or Advisory Role - Roche, Janssen Cilag
Travel, Accommodations, Expenses - Zentiva
 
Neil Segal
Consulting or Advisory Role - Agenus; AstraZeneca; Novartis; Numab; PureTech; regeneron
Research Funding - Agenus (Inst); AstraZeneca; Bristol-Myers Squibb; Merck; Pfizer; PureTech (Inst); Regeneron (Inst); Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Regeneron
 
Christophe Tournigand
Consulting or Advisory Role - Bayer; BMS; MSD; Pfizer
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BMS; SERVIER
(OPTIONAL) Uncompensated Relationships - Fondation APHP (Inst)
 
Stefan Kasper
Employment - University Hospital Essen (I)
Honoraria - Amgen; Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Lilly; Merck Serono; MSD Oncology; Novartis; Pierre Fabre; Roche; Sanofi/Aventis; SERVIER; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Incyte; Janssen-Cilag; Lilly; Merck Serono; MSD Oncology; Novartis; Pierre Fabre; Roche; Sanofi; SERVIER
Research Funding - Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; Roche/Genentech; SERVIER
Travel, Accommodations, Expenses - Amgen; BeiGene; BMS; Lilly; Merck Serono; Pierre Fabre; Roche; Sanofi
Other Relationship - Amgen; Bristol-Myers Squibb; Lilly; Merck Serono; Roche; Sanofi
 
Joan Maurel
Consulting or Advisory Role - Amgem, Delcath Systems, GSK, MSD, Incyte
Research Funding - Incyte, Terumo, Guardant
Travel, Accommodations, Expenses - Amgen, MSD
 
Sabine Tejpar
Consulting or Advisory Role - Agenus; Boehringer Ingelheim; GlaxoSmithKline
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; MSD; Roche; Sanofi
Research Funding - BMS GmbH & Co. KG; GlaxoSmithKline
Travel, Accommodations, Expenses - Amgen; Bayer; Merck Serono; Roche; Sanofi
 
Arun Gaddameedi
Employment - Novartis
 
Sumit Basu
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Gwendolyn Gobbo
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Yolanda Bi
Employment - Novartis
 
John Gregory
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Scott Kopetz
Stock and Other Ownership Interests - Frontier Medicines; Lutris; Navire
Consulting or Advisory Role - Alentis Therapeutics; AmMax Bio; Arcus Biosciences; AstraZeneca; AVEO; BeiGene; BioNTech SE; Boehringer Ingelheim; Bristol-Myers Squibb/Medarex; Carina Biotech; Clasp Therapeutics; Cytovation; Dewpoint Therapeutics; EMD Serono; Erasca, Inc; Flame Biosciences; Frontier Medicines; Genentech; Harbinger Oncology, Inc; Ikena Oncology; Iterion Therapeutics; Kivu Biosciences; Marengo Therapeutics; Pfizer; Regeneron; Roche; SageMedic; SERVIER; Shionogi; T-Cypher Bio; Tachyon Therapeutics; Transcode; XAIRA Therapeutics; Zentalis; Zentalis
Research Funding - Boehringer Ingelheim; EMD Serono; Genentech; Pfizer; Roche; Zentalis
 
Fernando Rivera
Honoraria - BMSi; MSD (Inst); SERVIER
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca Spain; BMSi; MSD
Research Funding - MSD (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - MSD